v3.26.1
Business Combination and Related Transactions - Schedule of Pro Forma Information, Adjustments (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Feb. 04, 2026
An increase in additional stock-based compensation expense related to shares issued to key Stereolabs employees in the acquisition that are considered compensatory in the post business combination periods due to the additional service requirement, net of the stock compensation expense already reflected in actual historical results.          
Business Combination [Line Items]          
Net loss $ 0 $ (780) $ (303) $ (1,560)  
A decrease (increase) in additional stock-based compensation expense related to the impact of the acceleration of Stereolabs warrants that vested at the close of the Stereolabs acquisition.          
Business Combination [Line Items]          
Net loss 0 0 207 (207)  
StereoLabs          
Business Combination [Line Items]          
Net loss (18,114) (22,663) (42,359) (54,511)  
Business combination, transaction cost incurred by seller         $ 3,000
StereoLabs | An increase in amortization expense related to the fair value of acquired identifiable intangible assets, net of the amortization expense already reflected in actual historical results.          
Business Combination [Line Items]          
Net loss 0 (1,184) (484) (2,368)  
StereoLabs | A decrease (increase) in expenses related to the transaction expenses. This amount includes $3.0 million in transaction expenses incurred by the sellers.          
Business Combination [Line Items]          
Net loss $ 0 $ 0 $ 4,137 $ (8,022)  
StereoLabs | Seller Acquisition-Related Cost          
Business Combination [Line Items]          
Business combination, transaction cost incurred by seller         $ 3,000